Lisanti Capital Growth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,285
Closed -$1.38M 115
2020
Q2
$1.38M Buy
9,285
+4,031
+77% +$543K 0.28% 101
2020
Q1
$572K Buy
5,254
+159
+3% +$18.4K 0.19% 104
2019
Q4
$587K Buy
+5,095
New +$508K 0.16% 109
2014
Q3
Sell
-9,140
Closed -$577K 94
2014
Q2
$577K Buy
+9,140
New +$543K 0.26% 92
2014
Q1
Sell
-15,140
Closed -$974K 98
2013
Q4
$974K Sell
15,140
-20,384
-57% -$1.22M 0.41% 87
2013
Q3
$2.27M Buy
35,524
+5,155
+17% +$257K 1.04% 41
2013
Q2
$1.4M Buy
+30,369
New +$808K 0.67% 63

Other funds holding ALNY